ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹15,953 Cr | ₹14,060 Cr | ₹12,454 Cr | ₹12,760 Cr | ₹10,411 Cr |
What is the latest Total Liabilities ratio of ALKEM LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹15,953 Cr |
| Mar2024 | ₹14,060 Cr |
| Mar2023 | ₹12,454 Cr |
| Mar2022 | ₹12,760 Cr |
| Mar2021 | ₹10,411 Cr |
How is Total Liabilities of ALKEM LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹15,953 Cr | 13.46 | |
| Mar2024 | ₹14,060 Cr | 12.89 | |
| Mar2023 | ₹12,454 Cr | -2.40 | |
| Mar2022 | ₹12,760 Cr | 22.56 | |
| Mar2021 | ₹10,411 Cr | - | |
Compare Total Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹66,259.0 Cr | -1.8% | -1.9% | 19.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -1.8% |
-1.9% |
19.6% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses